| Literature DB >> 26136831 |
Chete M Eze-Nliam1, Zugui Zhang1, Sandra A Weiss1, William S Weintraub1.
Abstract
Health care is a vital good for which there is an infinite demand. However, societal resources are finite and need to be distributed efficiently to avoid waste. Thus, the relative value of an intervention - cost compared to its effectiveness- needs to be taken into consideration when deciding which interventions to adopt. Cost-effectiveness analysis provides the crucial information which guides these decisions. As the field of medicine and indeed cardiology move forward with innovations which are effective but often expensive, it becomes imperative to employ these cost-effectiveness analytic tools, not with the intention of denying vital health services but to ascertain what the society willing to pay for.Entities:
Keywords: Bypass surgery; clinical trials; cost-effectiveness; percutaneous coronary intervention; transcatheter valve therapy
Year: 2014 PMID: 26136831 PMCID: PMC4484870 DOI: 10.2217/ica.13.81
Source DB: PubMed Journal: Interv Cardiol (Lond) ISSN: 1755-5302